Aflac (NYSE:AFL – Get Free Report) had its target price cut by equities research analysts at Keefe, Bruyette & Woods from $107.00 to $104.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “market perform” rating on the financial services provider’s stock. Keefe, Bruyette & Woods’ price objective would suggest a potential upside of 0.88% from the stock’s previous close.
AFL has been the topic of several other reports. Evercore ISI decreased their price objective on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research report on Wednesday, December 4th. Barclays decreased their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a report on Friday, February 7th. BMO Capital Markets assumed coverage on shares of Aflac in a report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price objective for the company. JPMorgan Chase & Co. upped their target price on shares of Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 7th. Finally, Truist Financial raised their price target on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $103.00.
View Our Latest Stock Report on Aflac
Aflac Stock Up 0.5 %
Aflac (NYSE:AFL – Get Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Equities research analysts expect that Aflac will post 6.95 earnings per share for the current fiscal year.
Insider Buying and Selling at Aflac
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the transaction, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.90% of the company’s stock.
Institutional Trading of Aflac
Large investors have recently modified their holdings of the business. Raymond James Financial Inc. purchased a new stake in Aflac in the 4th quarter worth approximately $163,409,000. Amundi raised its holdings in shares of Aflac by 81.1% during the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider’s stock valued at $285,181,000 after acquiring an additional 1,232,683 shares in the last quarter. Vanguard Group Inc. lifted its stake in Aflac by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider’s stock worth $5,310,640,000 after acquiring an additional 653,275 shares during the period. International Assets Investment Management LLC boosted its holdings in Aflac by 10,878.5% in the third quarter. International Assets Investment Management LLC now owns 559,903 shares of the financial services provider’s stock valued at $62,597,000 after acquiring an additional 554,803 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Aflac by 471.4% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 600,000 shares of the financial services provider’s stock valued at $67,080,000 after acquiring an additional 495,000 shares in the last quarter. 67.44% of the stock is owned by institutional investors.
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- Utilities Stocks Explained – How and Why to Invest in Utilities
- The Fast and the Casual: Is Taco Bell Catching Up to Chipotle?
- What is Put Option Volume?
- Broadcom Stock: Why the Upside Is Too Good to Ignore
- Why is the Ex-Dividend Date Significant to Investors?
- Citigroup Analysts Are Betting Big on These 3 Stocks—Should You?
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.